Search Results - "Kerr, Andrew J."

One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8) by Grey, Corina, Jackson, Rod, Schmidt, Morten, Ezzati, Majid, Asaria, Perviz, Exeter, Daniel J, Kerr, Andrew J

“…The aim of this study is to determine proportions of major ischaemic heart disease (IHD) events that are fatal and where they occur, in an era of rapidly…”
Get full text

Obesity and All Cause Mortality Following Acute Coronary Syndrome (ANZACS-QI 53) by Williams, Michael J.A., Lee, Mildred, Alfadhel, Mesfer, Kerr, Andrew J.

“…Some studies have suggested a lower mortality in obese subjects with cardiovascular disease. The aim of this study was to evaluate the relationship between…”
Get full text

MRI phase contrast velocity and flow errors in turbulent stenotic jets by O'Brien, Kieran R., Cowan, Brett R., Jain, Manali, Stewart, Ralph A.H., Kerr, Andrew J., Young, Alistair A.

“…Purpose To clarify the use of MRI phase contrast (PC), as an alternative to Doppler echocardiography, when measuring high‐velocity turbulent jets associated…”
Get full text

Twenty‐eight day and one‐year case fatality after hospitalisation with an acute coronary syndrome: a nationwide data linkage study by Grey, Corina, Jackson, Rod, Wells, Susan, Marshall, Roger, Riddell, Tania, Kerr, Andrew J.

“…To determine 28‐day and one‐year case fatality in patients hospitalised with acute coronary syndromes (ACS) and identify factors associated with mortality. All…”
Get full text

Clinical Characteristics and Burden of Risk Factors Among Patients With Early Onset Acute Coronary Syndromes: The ANZACS-QI New Zealand National Cohort (ANZACS-QI 17) by Earle, Nikki J., PhD, Poppe, Katrina K., COPSCT, PhD, Doughty, Robert N., MD, FRCP, FRACP, FESC, Rolleston, Anna, PhD, Kerr, Andrew J., MBChB, FRACP, Legget, Malcolm E., MD, FRACP

“…Background Cardiovascular (CV) risk factor profiles of people experiencing acute coronary syndromes (ACS) vary with age, and in New Zealand (NZ), Māori and…”
Get full text

The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55) by Chan, Daniel ZL, Stewart, Ralph AH, Kerr, Andrew J., Dicker, Bridget, Kyle, Campbell V., Adamson, Philip D., Devlin, Gerry, Edmond, John, El-Jack, Seif, Elliott, John M., Fisher, Nick, Flynn, Charmaine, Lee, Mildred, Liao, Yi-Wen (Becky), Rhodes, Maxine, Scott, Tony, Smith, Tony, Stiles, Martin K., Swain, Andrew H., Todd, Verity F., Webster, Mark WI, Williams, Michael JA, White, Harvey D., Somaratne, Jithendra B.

“…Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This…”
Get full text

Ethnic Differences in Coronary Revascularisation following an Acute Coronary Syndrome in New Zealand: A National Data-linkage Study (ANZACS-QI 12) by Grey, Corina, MBChB, MPH, FNZCPHM, Jackson, Rod, MBChB, PhD, FNZCPHM, Wells, Susan, MBChB, PhD, FNZCPHM, Randall, Deborah, BSc, MBiostat, Harwood, Matire, MBChB, PhD, Mehta, Suneela, MBChB, MPH, FNZCPHM, Exeter, Daniel J., BA, MA (Hons), PhD, Kerr, Andrew J., MBChB, FRACP

“…Background The aim of this study was to describe ethnic differences in angiography and revascularisation rates following an acute coronary syndrome (ACS) in…”
Get full text

Clinical Characteristics and Outcomes of Patients with Amphetamine-associated Cardiomyopathy in South Auckland, New Zealand by Kueh, Shaw-Hua (Anthony), MBChB, Gabriel, Ruvin S., MBChB, Lund, Mayanna, MBChB, Sutton, Tim, MBChB, Bradley, Joshua, MBChB, Kerr, Andrew J., MBChB, Looi, Jen-Li, MBChB

“…Background Amphetamine-associated cardiomyopathy (AAC) is becoming an increasingly recognised entity. The characteristics and outcomes of these patients are…”
Get full text

Aortic valve stenotic area calculation from phase contrast cardiovascular magnetic resonance: the importance of short echo time by O'Brien, Kieran R, Gabriel, Ruvin S, Greiser, Andreas, Cowan, Brett R, Young, Alistair A, Kerr, Andrew J

“…Cardiovascular magnetic resonance (CMR) can potentially quantify aortic valve area (AVA) in aortic stenosis (AS) using a single-slice phase contrast (PC)…”
Get full text

Clinical Characteristics and Outcome of Apical Ballooning Syndrome in Auckland, New Zealand by Looi, Jen-Li, MBChB, FRACP, Wong, Chi-Wing, FRACP, Khan, Ali, FRACP, Webster, Mark, FRACP, Kerr, Andrew J., FRACP

“…Background Apical ballooning syndrome (ABS) mimics myocardial infarction but is characterised by transient left ventricular (LV) dysfunction without…”
Get full text

Management and Long-Term Outcome of Acute Coronary Syndrome Patients Presenting with Heart Failure in a Contemporary New Zealand Cohort (ANZACS-QI 4) by Kueh, Shaw Hua (Anthony), MBChB, Devlin, Gerry, MBChB, Lee, Mildred, MSc, Doughty, Rob N., MBChB, Kerr, Andrew J., MBChB

“…Background Acute heart failure (HF) associated with an acute coronary syndrome (ACS) predicts adverse outcome. There have been important recent improvements in…”
Get full text

Myocardial Infarction Without Obstructive Coronary Artery Disease is Not a Benign Condition (ANZACS-QI 10) by Barr, Peter R, Harrison, Wil, Smyth, David, Flynn, Charmaine, Lee, Mildred, Kerr, Andrew J

“…Background Non-obstructive coronary artery disease (CAD) on coronary angiography after myocardial infarction (MI) is associated with a lower risk of adverse…”
Get full text

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33) by Foo, Fang Shawn, Lee, Mildred, Looi, Khang‐Li, Larsen, Peter, Clare, Geoffrey C., Heaven, David, Stiles, Martin K., Voss, Jamie, Boddington, Dean, Jackson, Rod, Kerr, Andrew J., Nunn, C., Sutcliffe, G., Devlin, G., White, H., Edmond, J., Tisch, J., Riddle, S., Marshall, K., Lund, M., Williams, M., Fisher, N., Scott, T., Sutherland, K., Flynn, C., Rhodes, M., Rattray, A., Chan, R., Jiang, Y., Jenkins, M., Faatui, J., Lindesay, M., Money, J., Singh, R., Chatburn, R., Kelly, R., Salmon, J., Visser, A., Youbard, J., Brett, S., Khan, S., Metrick, R., Harris, P., Sinclair, S., Jolly, B., Cheriyan, A., Riddell, F., Finnemore, H., Orsbourn, G., Williams, C., Turner, K., Maas, K., Donald, J., Kitipa, L., Cooper, L., Fowler, M., Brown, T., Takau, S., Chang, C., McLean, F., Smith, C., Allen, R., Timmins, K., Coley, K., Jones, P., Anthony‐Pudumai, N., Day, V., Stuit, V., Simms, L., Whiteley, C., Wilson, A., Jones, P., Hunter, K., Tait, S., Bishop, P., Cookley, M., Cumming, T., Goodson, J., Thacker, O., Guglietta, E., Milmine, V., Cotton, J., Wilson, L., Lawson, T., White, J., Breakwell, R., Searby, K., Slipper, D., Lipski, M., Sohil, A., Todd, K., Tilsley, C., Harris, K., Clayton, A., Moloney, L., Scott, B., Wylie, D.

“…Background The ANZACS‐QI Cardiac Implanted Device Registry (ANZACS‐QI DEVICE) collects nationwide data on cardiac implantable electronic devices in New Zealand…”
Get full text

Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders by Mehta, Suneela, Jackson, Rod, Pylypchuk, Romana, Poppe, Katrina, Wells, Sue, Kerr, Andrew J

“…Cardiovascular disease (CVD) risk prediction equations are primarily used in clinical settings to inform individual risk management decisions. We sought to…”
Get full text

How do cardiovascular risk prediction equations developed among 30–74 year olds perform in older age groups? A validation study in 125 000 people aged 75–89 years by Mehta, Suneela, Jackson, Rod, Poppe, Katrina, Kerr, Andrew J, Pylypchuk, Romana, Wells, Sue

“…BackgroundCardiovascular disease (CVD) risk prediction equations are being used to guide risk management among increasingly older individuals. We examined the…”
Get full text

Outcome after myocardial infarction without obstructive coronary artery disease by Williams, Michael J A, Barr, Peter R, Lee, Mildred, Poppe, Katrina K, Kerr, Andrew J

“…The medium-term outcome and cause of death in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) is not well characterised…”
Get more information

Guideline versus clinician recommended duration of dual antiplatelet therapy following acute coronary syndrome (ANZACS-QI 78) by Rees, Sophie J, Kerr, Andrew J

“…The recommended duration of dual anti-platelet therapy (DAPT) following acute coronary syndrome (ACS) for patients without atrial fibrillation varies from 1…”
Get full text

Comparison of electrographic changes, clinical features and outcomes in different variants of Takotsubo syndrome by looi, Jen-Li, Voss, Jamie, Gilmore, Jill, Heaven, David, Lee, Mildred, Kerr, Andrew J.

“…Dysfunction of the left ventricular (LV) apex (apical variant) is the most common form in Takotsubo syndrome (TS). Several less common non-apical variants have…”
Get full text

Cardiogenic Shock Prior to Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: Outcomes and Predictors of Mortality (ANZACS-QI 73) by Lee, Kyu Hyun, Harrison, Wil, Chow, Kok Lam, Lee, Mildred, Kerr, Andrew J.

“…Cardiogenic shock (CS) is a serious complication of acute myocardial infarction (MI) and is associated with significant mortality. We describe a contemporary,…”
Get full text

Performance Bounds for Target Parameter Estimation From Frequency-Domain Electromagnetic Induction Data by Kerr, Andrew J., Scott, Waymond R., McClellan, James H.

“…We derive the Cramer-Rao lower bounds (CRBs) for all target parameters associated with noisy measurements of a specific class of targets using a…”
Get full text